Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

We partner with medical device manufacturers in the U.S. and abroad to bring revolutionary products to market, navigate industry regulations, protect designs, drive business growth, and enhance and execute overall business strategies. Our regulatory counsel team manages interactions with governmental agencies, including the Centers for Medicaid and Medicare Services and the Food and Drug Administration, and our government affairs professionals help to identify and mobilize strategies for prompt product approvals and to respond to the challenges and capitalize on the opportunities presented by new regulations and changes in the marketplace. Whether developing a new product, seeking to enter a new market or pursuing a strategic acquisition or affiliation, our regulatory, corporate, transactional and IP attorneys leverage industry-specific insights to help medical device companies advance their goals.

Insights & Events

Insights
Updates August 2025

The EU Data Act: Impact on Connected Products and Device Manufacturers

Any Organisation Established Outside the EU but Operating in the EU Market Will Potentially Fall Within Scope
14 min read  
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read  
Media Mentions June 2025

Bench & Bar of Minnesota Highlights New MSBA President Tom Pack’s Approach to Leadership

1 min read  
Updates June 2025

Future Damages and Future Injunction May Constitute Double Recovery in Trade Secrets Case

Insulet Corporation v. EO Flow Co., Ltd.
4 min read  
Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Updates April 2025

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

Biopharma & Medical Devices Briefing
5 min read  
Updates April 2025

Comment Period Open for Massive New PFAS Reporting Requirements in Minnesota

Deadline for Written Comments Is May 21, 2025
3 min read  
Published Articles April 2025

Product Liability and Mass Torts Attorneys Contribute to International Comparative Legal Guides’ ‘Drug and Medical Device Litigation 2025’ Guide

1 min read